P eak exercise oxygen consumption (peak VO 2 ), as measured by expired gas analysis, is an accurate, reproducible and reliable method for determining exercise capacity. In this study, a cohort of 468 patients with type 2 diabetes underwent graded exercise testing to measure peak VO 2 at baseline; the cohort was followed for five years for the occurrence of cardiovascular disease (CVD) events. Patients who developed CVD events during the five-year follow-up period were found to have significantly lower baseline peak VO 2 , as compared to those who did not (p=0.02). Analysis by gender showed that the mean peak VO 2 in male patients who developed CVD events was significantly lower than the peak VO 2 in those who did not (p<0.03). Multiple Cox regression analysis also showed low peak VO 2 to be an independent factor.
Introduction
Cardiovascular disease is a leading cause of morbidity and mortality in people with type 2 diabetes mellitus, accounting for a 2-4-fold increase in the overall mortality. 1 Various reports have shown that regular physical activity is associated with a reduced risk of coronary heart disease. [2] [3] [4] [5] Regular physical activity is in turn associated with higher levels of physical fitness, as measured by maximal oxygen uptake and heart rate response to submaximal exercise. 6, 7 Physical training increases the maximal oxygen uptake in the body. The increase in maximal O 2 uptake in healthy subjects is a result of an increase in peak cardiac output and an increased extraction of O 2 from the blood. Additionally, the beneficial effect of physical training has been attributed to changes in skeletal muscles and to an increase in arterial O 2 content. 8 Some, although not all, previous studies have suggested that subjects with uncomplicated type 2 diabetes mellitus have an impaired peak exercise performance compared with healthy age-matched controls. [9] [10] [11] [12] [13] The impairment in exercise is not associated with the degree of glycaemic control. 13 However, the mechanism by which exercise performance is impaired in persons with type 2 diabetes is not known. Nevertheless, lifestyle modification, including exercise, remains an integral part of the management of diabetes mellitus and has been shown to prevent progression from impaired glucose tolerance to diabetes. 14 Peak exercise oxygen consumption (peak VO 2 ) as measured by expired gas analysis serves as an accurate, reproducible and reliable method for determining exercise capacity. However, limited data are available on the relation between physical fitness as measured by exercise testing and subsequent cardiovascular morbidity and mortality. [15] [16] [17] [18] The purpose of this study was to determine the predictive value of baseline peak exercise oxygen consumption on subsequent development of cardiovascular events in a cohort of 468 patients with type 2 diabetes during a five-year followup period.
Research design and methods

Study population
The study subjects were participants in the Appropriate Blood Pressure Control in Diabetes (ABCD) trial, a large, prospective, randomised, blinded clinical study designed to determine the effects of moderate versus intensive blood pressure control on the outcome of complications in type 2 diabetes. This trial has been described in detail previously. 19 Participants in the ABCD trial between the ages of 40 and 74 years were identified from diagnosis-related group and phar-macy and billing lists from participating hospitals. Individuals found to be eligible after an initial phone screen and eligibility visit were enrolled into this study.
The diagnosis of type 2 diabetes mellitus for all patients enrolled in the ABCD trial was made according to criteria based on the World Health Organization report of 1985, 20 which followed the National Diabetes Group criteria of 1979. 21 Institutional Review Board approval was obtained for the conduct of all aspects of the ABCD trial, and all eligible patients gave informed consent for participating in the study.
During the pre-randomisation period, participants were tapered off all pre-existing antihypertensive agents, and placebo was prescribed for a minimum of seven and a maximum of 11 weeks. 22 During this period, all baseline examinations were performed. Thus, all baseline exercise tests and peak VO 2 measurements were performed after 7-11 weeks of wash-out from any antihypertensive medications. A structured interview with detailed questions regarding medications and history of cardiovascular disease also took place. Patients with a history of coronary artery disease at baseline were excluded from the study.
Exercise testing and measurement of peak oxygen consumption (peak VO 2 )
An exercise treadmill test was administered during the prerandomisation period using a Half Bruce protocol. 23 The electrocardiogram was monitored continuously (Q5000 Exercise Monitor; Quinton, Seattle, WA) and blood pressure was measured at the end of each stage by an automated blood pressure cuff (model 412 automated blood pressure cuff; Quinton). Patients exercised until symptoms forced them to stop. Measurements of oxygen consumption and carbon dioxide production, with calculations of the respiratory exchange ratios, were performed continuously using an automated gas exchange measuring system (Q-plex Metabolic Cart; Quinton). Values were recorded at 15-second intervals. The respiratory exchange ratio (RER), the ratio of carbon dioxide production to oxygen consumption, was used as a measure of exercise intensity. Peak VO 2 was defined as oxygen consumption (ml kg -1 min -1 ) at peak exercise and was calculated as the mean of values during the last minute of exercise. To ensure an adequate effort, only patients who reached RER > 1.0 were included in the analysis; 43 patients who were not able to reach RER of 1.0 were excluded. Thus, the cohort study population was 468 patients with type 2 diabetes mellitus.
CVD events
An independent end point committee, which was blinded to the study intervention arms, reviewed all cardiovascular events. Cardiovascular disease (CVD) events were defined as follows: 1) death due to cardiovascular events (sudden death, progressive heart failure, myocardial infarction, arrhythmias, cerebral vascular accidents, and ruptured aortic aneurysm); 2) non-fatal myocardial infarction; 3) non-fatal cerebral vascular accident; 4) heart failure requiring hospital admission; and 5) pulmonary infarction. The end point committee reviewed and confirmed all cardiovascular events.
Albuminuria and retinopathy were classified as described in earlier reports. 24 Statistical analysis Univariate analysis was performed relating peak O2 consumption with cardiovascular events that developed over time and with various other clinical factors. Multiple regression analysis was performed, controlling for age, sex, duration of diabetes, hypertension and body mass index. All results were reported as means + or -standard error (SE).
Results
Baseline clinical and laboratory characteristics
A cohort of 468 patients with type 2 diabetes, 307 (65.6%) males and 161 (34.4%) females, was followed for a period of five years. Table 1 shows the baseline clinical and laboratory characteristics, categorised according to subsequent development of CVD events. The mean age of those who subsequently developed CVD events was higher when compared to those who did not. Duration of diabetes, level of systolic To convert cholesterol from mg/dL to mmol/L, multiply by 0.02586 To convert triglycerides from mg/dL to mmol/L, multiply by 0.01129 blood pressure, prevalence of microvascular complications (retinopathy and nephropathy) and high-density lipoprotein (HDL)-cholesterol levels were significantly different at baseline among the two groups; on the other hand, duration of hypertension, levels of diastolic blood pressure, body mass index, pack years of smoking, prevalence of peripheral vascular disease and low-density lipoprotein (LDL)-cholesterol were similar in the two groups.
When these profiles were analysed by gender (table 2) , the mean age, duration of diabetes, duration of hypertension, diastolic blood pressure and prevalence of retinopathy were similar among males and females. The pack years of smoking, left ventricular mass and prevalence of nephropathy were significantly higher in males than in females. However, females had higher body mass index (BMI), total cholesterol, HDL-cholesterol, and glycosylated haemoglobin levels (table 2) .
Peak exercise oxygen consumption and CVD
Patients in the total cohort who developed cardiovascular events during the five years of follow-up demonstrated significantly lower peak exercise oxygen consumption at baseline than patients who did not (20.3+0.6 ml kg -1 min -1 versus 21.9+0.3 ml kg -1 min -1 ) (figure 1). For the entire cohort of patients, male subjects had a significantly higher peak VO 2 at baseline than female subjects (23.3+0.27 ml kg -1 min -1 in males versus 18.5+0.37 ml kg -1 min -1 in females, p<0.0001) (data not shown). Of the 307 male patients, 51 (16.6%) and of the 161 female patients, 20 (12.4%) patients developed CVD events during the fiveyear follow-up period. The difference in incidence of CVD events among the males and females was not statistically significant (p>0.05). Figure 2 shows that the mean peak VO 2 at baseline in the male patients who developed CVD events was significantly lower than in those who did not develop CVD events (21.9+0.7 ml kg -1 min -1 versus 23.6+0.3 ml kg -1 min -1 , p<0.03). Similarly, the mean peak VO 2 in the female patients who developed CVD events was significantly lower than in those who did not ORIGINAL ARTICLE To evaluate the relative influence of several concurrent variables on the development of CVD events, multiple Cox proportional regression analysis was performed. The model included age, gender, duration of diabetes, duration of hypertension, blood pressure, overt albuminuria and total serum cholesterol. The results (table 3) showed that, in addition to duration of diabetes and overt albuminuria, peak VO 2 is also an independent factor in predicting CVD events (p=0.0165).
Discussion
In this study, we have demonstrated that lower peak VO 2 at baseline is associated with a higher rate of subsequent cardiovascular events when the entire cohort of patients with type 2 diabetes was analysed (figure 1). Male patients who subsequently developed CVD events had significantly lower baseline peak VO 2 than those who did not develop CVD events. Similarly, females who developed CVD events also had lower peak VO 2 than those who did not develop CVD events (figure 2). Overall, male patients had significantly higher peak VO 2 than females whether they did or did not develop CVD events (figure 2).
Exercise capacity is determined by the interplay of the fundamental physiological processes of the body. The micro-and macro-vascular complications observed in the patient with diabetes dictate the subject's capacity to perform exercise, which is manifest with lower peak VO 2 consumption and eventually signals future clinical cardiovascular events. In this regard (as shown in table 1), patients who developed CVD events were significantly older, with longer duration of diabetes, higher systolic blood pressure and higher prevalence of microvascular complications than those patients who did not develop CVD events. Thus, the lower peak VO 2 at baseline in such subjects most likely represents pre-existing sub-clinical micro-and macro-vascular disease. Nonetheless, we have demonstrated in the multiple Cox proportional hazards model that, after adjusting for other variables, low peak VO 2 is an independent and significant predictor of future clinical CVD events.
Exercise is a major component in the management of patients with type 2 diabetes and peak VO 2 can be a reliable method for determining exercise capacity. Exercise increases insulin sensitivity and peripheral tissue glucose disposal, which helps to achieve optimum metabolic control. Peak VO 2 is directly correlated with insulin-stimulated glucose disposal. [25] [26] [27] Decreased peak VO 2 has been observed in patients with insulin resistance and in their relatives; however, this trend can improve with intensive and regular physical training. 28 In exercise, both an increase in peak cardiac output and an increased extraction of oxygen from the blood increase maximal oxygen uptake. The increase in cardiac output in trained normal subjects occurs because of an increase in stroke volume. 13, 29 However, the beneficial effect of physical training in persons with coronary heart disease has been attributed primarily to peripheral mechanisms 30, 31 such as changing adaptive mechanisms, which increase arterial oxygen content, and to increases in muscle oxygen extraction. 8 Urinary albumin excretion is associated with left ventricular dysfunction, 32, 33 and has also been reported to predict future cardiovascular events in European patients with type 2 diabetes 34, 35 and to impair exercise capacity in patients with diabetes. 36 However, there have been no reports to demonstrate the predictive power of peak VO 2 in future cardiovascular events in patients with type 2 diabetes mellitus. In the present study, those patients who developed cardiovascular events not only had lower peak VO 2 at baseline but also a higher prevalence of retinopathy and nephropathy. Thus, decreased peak VO 2 is one of several pathophysiological mechanisms leading to the time-dependent development of cardiovascular events in patients with type 2 diabetes mellitus.
Our group has previously reported that increasing urinary albumin excretion was directly associated with a decrease in exercise capacity. 37 This microvascular diabetic complication was associated with a decrease in exercise performance as measured by peak VO 2 , independent of age, gender, race, duration of diabetes, duration of hypertension, BMI and glycosylated haemoglobin levels. In another study where assessments of demographic and cardiovascular risk factors were undertaken, the results revealed that age, obesity, systolic blood pressure, smoking and African-American race were independently associated with an impairment of exercise capacity. 38 Thus, decreased peak VO 2 appears to be associated with multiple factors involved in the complications of diabetes. While macrovascular disease in general and CVD in particular represent the leading causes of morbidity and mortality in type 2 diabetes, 1 there are currently limitations in the ability to assess the risk for further clinical events non-invasively.
The present study has demonstrated that low peak VO 2 at baseline is independently associated with the future development of cardiovascular events. Since diabetes mellitus is a multi-organ disease, peak VO 2 is likely to be dependent on various other concurrent factors involved in the microvascular and macrovascular complications of the dis-ORIGINAL ARTICLE ease. Further prospective studies would be required to determine the utility of peak VO 2 measurement during exercise as an indicator for future cardiovascular events in patients with type 2 diabetes.
